Halozyme Therapeutics submitted a bid to acquire German drug developer Evotec in a deal with an equity value of 2 billion euros ($2.11 billion.) ...
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team Storage-Area Networking (SAN) DIEGO, ...
Last year, Nvidia announced that a group of talented modders were working on fully remastering Half-Life 2, including adding ...
Germany’s Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., ...
Major Bank Warns Against Trump’s ‘Nightmare’ Economic Agenda ...
The current Mustang’s DC2 platform awaits Lincoln’s tinkering. Let’s imagine what that collaboration would look and feel like ...
Halo Studios, aka 343 Industries, have confirmed that Halo Infinite campaign updates are not happening, so new weapons won't ...